Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression
Rodolfo Myronn de Melo Rodrigues
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (15)
- Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial. 2024-06-01 · Expand citations
- Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. 2024-05-15 · Expand citations
- Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. 2024-03-08 · Expand citations
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin. 2024-01-01 · Expand citations
- Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy? 2023-12-01 · Expand citations
- Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. 2023-09-01 · Expand citations
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
- Psychedelics in the treatment of unipolar and bipolar depression. 2022-07-05 · Expand citations
- Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. 2022-03-15 · Expand citations
- OpenAlex W3204230901
- OpenAlex W4385628167
- OpenAlex W4387521434
- OpenAlex W4395685207
- OpenAlex W4398774731
- OpenAlex W4404286069
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.